Eye-to-eye Innovation Series

Eye-to-Eye Innovation Series

COMPASS Fundus Automated Perimetry is the new standard in Visual Field testing
COMPASS Fundus Automated Perimetry is the new standard in Visual Field testingDr. Francesco Oddone, Head of the Glaucoma Research Unit at Bietti Foundation, Rome, speaks about the most interesting features of COMPASS, the unique automatic perimeter combined with a scanning ophthalmoscope, able to provide retinal threshold sensitivity as well as confocal images of the retina.
Prof. Michael Knorz: Three reasons to buy a SCHWIND AMARIS laser system
Prof. Michael Knorz: Three reasons to buy a SCHWIND AMARIS laser systemProf. Michael Knorz, Founder & CEO, FreeVis LASIK Group, Germany, tells the reasons why he bought a new SCHWIND AMARIS laser system in 2017.
Dr. David Lin: Experiences with SCHWIND SmartSurfACE treatment
Dr. David Lin: Experiences with SCHWIND SmartSurfACE treatmentDavid Lin, MD, Medical Director Pacific Laser Eye Centre in Vancouver, Canada, shares his experiences with SCHWIND SmartSurfACE treatment and how this procedure completely transformed the way of the clinic performing laser surgery.
ZEISS Cataract Suite markerless – for markerless toric IOL alignment
ZEISS Cataract Suite markerless – for markerless toric IOL alignmentDr. David Chang, M.D. describes his experience with ZEISS Cataract Suite markerless.
Multiple Imaging Modalities based on Eidon Technology
Multiple Imaging Modalities based on Eidon TechnologyGiovanni Staurenghi, professor of Ophthalmology at the University of Milan speaks about OCT, infrared, and autofluorescence base images used in practice. He explains how using blu autofluorescence imaging speeds up flow in cleaning and helps in diagnosis.
Innovation leadership with AMARIS features SmartPulse Technology and TransPRK
Innovation leadership with AMARIS features SmartPulse Technology and TransPRKBruce Allan, MD, UK and David Kang, MD, South Korea, are SCHWIND users for many years. Both greatly appreciate the outstanding performance features offered by the SCHWIND AMARIS excimer laser technology. The company‘s spirit of innovation, their willingness to advance the art and science of refractive surgery, and their responsiveness to feedback. In this video, Dr. Allan and Dr. Kang comment on the sophisticated SCHWIND AMARIS features SmartPulse Technology and TransPRK.
Refractive Surprises – Are They Really Taboo?
Refractive Surprises – Are They Really Taboo?Professor Rudy Nuijts, Professor James Wolffsohn, Dr Mark Cherny and Dr David Frazer share their views on the taboo topic of refractive surprise in cataract surgery. They explain what it means to have a refractive surprise, why they occur, the importance of patient satisfaction and the options available to surgeons (including Rayner Sulcoflex® case studies) when a situation involving a refractive surprise arises.
Efficacy of Ozurdex in DME in the real world clinical setting-Leowenstein interview
Efficacy of Ozurdex in DME in the real world clinical setting-Leowenstein interviewProfessor Anat Lowenstein talks about the impact of Ozurdex in treating diabetic macular edema (DME) in the real world clinical setting. This renowned expert in the DME field, explores what the licensing of Ozurdex in DME means to both patients and retinal specialists when treating this potentially blinding condition.
Efficacy of Ozurdex in DME in the real world clinical setting-DeSmet Interview
Efficacy of Ozurdex in DME in the real world clinical setting-DeSmet InterviewProfessor Marc De Smet talks about the impact of Ozurdex in treating diabetic macular edema (DME) in the real world clinical setting. This renowned expert in the DME field, explores what the licensing of Ozurdex in DME means to both patients and retinal specialists when treating this potentially blinding condition.
Rayner's Recently Acquired Ophteis OVD Range and What This Means for Cataract Surgery
Rayner's Recently Acquired Ophteis OVD Range and What This Means for Cataract SurgeryProfessor Steve Arshinoff and Rayner CEO Tim Clover announce Rayner's recent acquisition of the Ophteis OVD range at the Company's celebratory event, held at the 2015 ESCRS in Barcelona.